Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name FT516
Trade Name
Synonyms FT-516|iPSC-derived CD16-expressing Natural Killer Cells FT516
Drug Descriptions

FT516 are iPSC-derived allogeneic NK cells engineered to express hnCD16, which may stimulate anti-tumor immune response (Cancer Res 2019;79(13 Suppl):Abstract nr 3191).

CAS Registry Number NA
NCIT ID C164140


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Aldesleukin + Cyclophosphamide + Fludarabine + FT516 Aldesleukin Cyclophosphamide FT516 Fludarabine 0 1
Aldesleukin + Cyclophosphamide + Fludarabine + FT516 + Obinutuzumab Aldesleukin Cyclophosphamide FT516 Fludarabine Obinutuzumab 0 1
Aldesleukin + Cyclophosphamide + Fludarabine + FT516 + Rituximab Aldesleukin Cyclophosphamide FT516 Fludarabine Rituximab 0 1
Aldesleukin + FT516 Aldesleukin FT516 0 1
Aldesleukin + FT516 + MGA271 Aldesleukin FT516 MGA271 0 1
Avelumab + FT516 Avelumab FT516 0 1
FT516 FT516 0 0
FT516 + Rituximab FT516 Rituximab 0 0

Additional content available in CKB BOOST